VASH1 and ovarian cancer: ECM receptors are the main regulatory pathways that control various cellular processes, including survival, proliferation, migration, invasion, DNA damage, signal transduction, and repair.39 Downregulation of ECM composition and structure is related to carcinogenesis and cancer progression.40,41 Therefore, we suspect that the upregulation of VASH1 is positively correlated with the ECM receptor to inhibit ovarian cancer metastasis and that VASH1 may be a possible therapeutic target.